GSK plc
The Head of Oncology Clinical Development-ADCs leads the design and implementation of clinical development strategies for multi‑tumor oncology assets, overseeing early‑ to late‑phase programs, regulatory filings, and initial market launch. This senior cross‑matrix leader drives scientific positioning, portfolio alignment, and innovative approaches while representing Clinical Development in high‑impact governance and external forums.
Headquarters
London, England, United Kingdom
Company Size
10001+ employees
Founded
1830
At GSK, we unite science, technology and talent to get ahead of disease together
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for GSK plc.
55% above the average for this role
GSK enters agreement with U.S. government to lower drug prices and expand access to respiratory medicines for millions of Americans
Dec 19, 2025
Medical Director – Hematology/Oncology (12-Month Temporary Basel)
Roche
Senior Director, Translational Medicine B-cell NHL & Leukemia
AstraZeneca
Global Project Head, Solid Tumor Antibody Drug Conjugates (ADCs)
sanofi us
Clinical Director Oncology (Principal Scientist, MD)
MSD
Senior Director Translational Medicine B Cell Nhl Leukemia Waltham Massachusetts United States Of America
AstraZeneca
Director for Breast Medical Oncology Clinical Research
oraclecloudinfrastructure